DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nitrofurantoin (Nitrofurantoin) - Craniosynostosis - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Craniosynostosis (11)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Nitrofurantoin where reactions include craniosynostosis. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Nitrofurantoin side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-14

Patient: male

Reactions: Cytogenetic Abnormality, Dysmorphism, Maternal Drugs Affecting Foetus, Glaucoma, Pneumonia Aspiration, Micrognathia, Pierre Robin Syndrome, Caesarean Section, Cleft Palate, Developmental Delay, Respiratory Disorder Neonatal, Laryngomalacia, Gastrooesophageal Reflux Disease, Myopia, Ear Infection, Torticollis, Deafness Congenital, Respiratory Distress, Hyperbilirubinaemia Neonatal, Craniosynostosis, Bronchial Hyperreactivity, Respiratory Tract Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Codeine Phosphate, Guaifenesin (Cheracol / 00693301 / )
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Olopatadine Hydrochloride
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Nitrofurantoin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication

Cetirizine
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Azithromycin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Topiramate
    Dosage: 50 mg (25 mg, 2 in 1 d), transplacental
    Indication: Migraine
    Start date: 2010-03-15
    End date: 2010-04-15

Amoxicillin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Ibuprofen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Hydrocodone Bitartrate and Acetaminophen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Sumatriptan
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Fluticasone Propionate
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Cyclobenzaprine
    Dosage: 30 mg (10 mg, 3 in 1 d), transplacental
    Indication: Sciatic Nerve Injury

Naproxen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Prenatal Vitamins (Prenatal Viotamins / 01549301 / )
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication



Possible Nitrofurantoin side effects in male

Reported by a lawyer from United States on 2012-05-08

Patient: male

Reactions: Pneumonia Aspiration, Respiratory Disorder, Hyperbilirubinaemia, Glaucoma, Pneumonia, Deafness, Pierre Robin Syndrome, Ear Infection, Torticollis, Maternal Exposure Timing Unspecified, Cleft Palate, Body Dysmorphic Disorder, Craniosynostosis, Developmental Delay, Bronchial Hyperreactivity, Gastrooesophageal Reflux Disease

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cetirizine Hydrochloride
    Dosage: unk
    Start date: 2010-03-25

Amoxicillin
    Dosage: unk
    Start date: 2010-03-25

Topamax
    Dosage: 25 mg four times a day for 1 week

Topamax
    Dosage: 25 mg in the morning and 25 mg at night for 1 week

Nitrofurantoin
    Dosage: unk

Naproxen
    Dosage: unk
    Start date: 2010-03-25

Sumitriptan Succinate
    Dosage: unk
    Start date: 2010-03-25

Topamax
    Dosage: 25 mg two times a day
    Indication: Migraine
    Start date: 2010-03-15
    End date: 2010-04-15

Flexeril
    Dosage: 10 mg, 3x/day
    Indication: Sciatic Nerve Injury

Multi-Vitamins
    Dosage: unk

Fluticasone Propionate
    Dosage: unk
    Start date: 2010-03-25

Olopatadine HCL
    Dosage: unk
    Start date: 2010-03-25

Ibuprofen
    Dosage: unk
    Start date: 2010-03-25

Topamax
    Dosage: 25 mg two times a day for 1 week

Cheracol / USA /
    Dosage: unk
    Start date: 2010-03-25

Vicodin
    Dosage: unk
    Start date: 2010-03-25

Azithromycin
    Dosage: unk
    Start date: 2010-03-25



Possible Nitrofurantoin side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-04

Patient: male

Reactions: Hyperbilirubinaemia, Maternal Drugs Affecting Foetus, Respiratory Disorder, Pneumonia Aspiration, Glaucoma, Pierre Robin Syndrome, Deafness, Torticollis, Body Dysmorphic Disorder, Craniosynostosis, Cleft Palate, Developmental Delay, Bronchial Hyperreactivity, Gastrooesophageal Reflux Disease

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Amoxicillin
    Indication: Foetal Exposure During Pregnancy

Multi-Vitamins
    Indication: Foetal Exposure During Pregnancy

Guaifenesin / Codeine
    Indication: Foetal Exposure During Pregnancy

Ibuprofen
    Indication: Foetal Exposure During Pregnancy

Sumatriptan Succinate
    Indication: Foetal Exposure During Pregnancy

Cetirizine HCL
    Indication: Foetal Exposure During Pregnancy

Fluticasone Propionate
    Indication: Foetal Exposure During Pregnancy

Hydrocodone Bitartrate + Acetaminophen
    Indication: Foetal Exposure During Pregnancy

Olopatadine HCL
    Indication: Foetal Exposure During Pregnancy

Topamax
    Indication: Foetal Exposure During Pregnancy
    End date: 2010-11-01

Flexeril
    Indication: Foetal Exposure During Pregnancy

Nitrofurantoin
    Indication: Foetal Exposure During Pregnancy

Azithromycin
    Indication: Foetal Exposure During Pregnancy

Naproxen
    Indication: Foetal Exposure During Pregnancy



Possible Nitrofurantoin side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-04

Patient: male

Reactions: Hyperbilirubinaemia, Maternal Drugs Affecting Foetus, Cytogenetic Abnormality, Glaucoma, Pierre Robin Syndrome, Deafness, Micrognathia, Body Dysmorphic Disorder, Cleft Palate, Caesarean Section, Developmental Delay, Cough, Dyspnoea, Chest Discomfort, Myopia, Craniosynostosis, Bronchial Hyperreactivity

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclobenzaprine
    Dosage: 30 mg (10 mg, 3 in 1 d), transplacental
    Indication: Sciatic Nerve Injury

Amoxicillin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Topiramate
    Dosage: 50;100;1w mg (25 mg, 2 in 1 d), transplacental
    Indication: Migraine

Naproxen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Sumatriptan
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Nitrofurantoin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication

Hydrocodone Bitartrate and Acetaminophen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Prenatal Vitamins (Prenatal Vitamins (01549301)
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication

Fluticasone Propionate
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Azithromycin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Ibuprofen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Cetirizine
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Codeine Phosphate, Guaifenesin (Cheracol / 00693301 / )
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Olopatadine Hydrochloride
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25



Possible Nitrofurantoin side effects in male

Reported by a lawyer from United States on 2012-05-01

Patient: male

Reactions: Pneumonia Aspiration, Glaucoma, Hyperbilirubinaemia, Cytogenetic Abnormality, Respiratory Disorder, Maternal Drugs Affecting Foetus, Deafness, Pierre Robin Syndrome, Caesarean Section, Cleft Palate, Body Dysmorphic Disorder, Respiratory Disorder Neonatal, Developmental Delay, Laryngomalacia, Gastrooesophageal Reflux Disease, Pneumonia, Myopia, Ear Infection, Torticollis, Maternal Exposure Timing Unspecified, Respiratory Distress, Hyperbilirubinaemia Neonatal, Craniosynostosis, Bronchial Hyperreactivity, Respiratory Tract Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Topamax
    Dosage: 25 mg in the morning and 25 mg at night for 1 week

Topamax
    Dosage: 25 mg two times a day for 1 week

Fluticasone Propionate
    Dosage: unk
    Start date: 2010-03-25

Olopatadine HCL
    Dosage: unk
    Start date: 2010-03-25

Azithromycin
    Dosage: unk
    Start date: 2010-03-25

Topamax
    Dosage: 25 mg four times a day for 1 week

Cheracol / USA /
    Dosage: unk
    Start date: 2010-03-25

Flexeril
    Dosage: 10 mg, 3x/day
    Indication: Sciatic Nerve Injury

Ibuprofen
    Dosage: unk
    Start date: 2010-03-25

Topamax
    Dosage: 25 mg two times a day
    Indication: Migraine
    Start date: 2010-03-15
    End date: 2010-04-15

Nitrofurantoin
    Dosage: unk

Multi-Vitamins
    Dosage: unk

Vicodin
    Dosage: unk
    Start date: 2010-03-25

Naproxen
    Dosage: unk
    Start date: 2010-03-25

Cetirizine HCL
    Dosage: unk
    Start date: 2010-03-25

Amoxicillin
    Dosage: unk
    Start date: 2010-03-25

Sumatriptan Succinate
    Dosage: unk
    Start date: 2010-03-25



Possible Nitrofurantoin side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-27

Patient: male

Reactions: Respiratory Disorder, Pneumonia Aspiration, Hyperbilirubinaemia, Glaucoma, Deafness, Pierre Robin Syndrome, Craniosynostosis, Body Dysmorphic Disorder, Cleft Palate, Developmental Delay, Bronchial Hyperreactivity

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Nitrofurantoin
    Indication: Foetal Exposure During Pregnancy

Topamax
    Indication: Foetal Exposure During Pregnancy
    End date: 2010-11-01

Flexeril
    Indication: Foetal Exposure During Pregnancy

Cetirizine HCL
    Indication: Foetal Exposure During Pregnancy

Amoxicillin
    Indication: Foetal Exposure During Pregnancy

Sumatriptan Succinate
    Indication: Foetal Exposure During Pregnancy

Guaifenesin / Codeine
    Indication: Foetal Exposure During Pregnancy

Olopatadine HCL
    Indication: Foetal Exposure During Pregnancy

Ibuprofen
    Indication: Foetal Exposure During Pregnancy

Multi-Vitamins
    Indication: Foetal Exposure During Pregnancy

Azithromycin
    Indication: Foetal Exposure During Pregnancy

Fluticasone Propionate
    Indication: Foetal Exposure During Pregnancy

Naproxen
    Indication: Foetal Exposure During Pregnancy

Hydrocodone Bitartrate + Acetaminophen
    Indication: Foetal Exposure During Pregnancy



Possible Nitrofurantoin side effects in male

Reported by a lawyer from United States on 2012-04-25

Patient: male

Reactions: Pneumonia, Glaucoma, Respiratory Disorder, Hyperbilirubinaemia, Ear Infection, Deafness, Pierre Robin Syndrome, Maternal Exposure Timing Unspecified, Cleft Palate, Craniosynostosis, Body Dysmorphic Disorder, Developmental Delay

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Olopatadine HCL
    Dosage: unk
    Start date: 2010-03-25

Ibuprofen
    Dosage: unk
    Start date: 2010-03-25

Flexeril
    Dosage: 10 mg, 3x/day
    Indication: Sciatic Nerve Injury

Sumatriptan Succinate
    Dosage: unk
    Start date: 2010-03-25

Topamax
    Dosage: 25 mg two times a day
    Indication: Migraine
    Start date: 2010-03-15
    End date: 2010-04-15

Topamax
    Dosage: 25 mg in the morning and 25 mg at night for 1 week

Topamax
    Dosage: 25 mg four times a day for 1 week

Nitrofurantoin
    Dosage: unk

Multi-Vitamins
    Dosage: unk

Cetirizine HCL
    Dosage: unk
    Start date: 2010-03-25

Topamax
    Dosage: 25 mg two times a day for 1 week

Amoxicillin
    Dosage: unk
    Start date: 2010-03-25

Azithromycin
    Dosage: unk
    Start date: 2010-03-25

Cheracol / USA /
    Dosage: unk
    Start date: 2010-03-25

Fluticasone Propionate
    Dosage: unk
    Start date: 2010-03-25

Naproxen
    Dosage: unk
    Start date: 2010-03-25

Vicodin
    Dosage: unk
    Start date: 2010-03-25



Possible Nitrofurantoin side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-23

Patient: male

Reactions: Glaucoma, Respiratory Disorder, Hyperbilirubinaemia, Pierre Robin Syndrome, Deafness, Cleft Palate, Body Dysmorphic Disorder, Craniosynostosis, Developmental Delay

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Topamax
    Indication: Foetal Exposure During Pregnancy
    End date: 2010-11-01

Amoxicillin
    Indication: Foetal Exposure During Pregnancy

Flexeril
    Indication: Foetal Exposure During Pregnancy

Guaifenesin / Codeine
    Indication: Foetal Exposure During Pregnancy

Multi-Vitamins
    Indication: Foetal Exposure During Pregnancy

Fluticasone Propionate
    Indication: Foetal Exposure During Pregnancy

Ibuprofen
    Indication: Foetal Exposure During Pregnancy

Nitrofurantoin
    Indication: Foetal Exposure During Pregnancy

Olopatadine HCL
    Indication: Foetal Exposure During Pregnancy

Azithromycin
    Indication: Foetal Exposure During Pregnancy

Cetirizine HCL
    Indication: Foetal Exposure During Pregnancy

Hydrocodone Bitartrate and Acetaminophen
    Indication: Foetal Exposure During Pregnancy

Sumatriptan Succinate
    Indication: Foetal Exposure During Pregnancy

Naproxen
    Indication: Foetal Exposure During Pregnancy



Possible Nitrofurantoin side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-20

Patient: male

Reactions: Respiratory Disorder, Glaucoma, Hyperbilirubinaemia, Deafness, Pierre Robin Syndrome, Craniosynostosis, Body Dysmorphic Disorder, Cleft Palate, Developmental Delay

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Nitrofurantoin
    Indication: Foetal Exposure During Pregnancy

Topamax
    Indication: Foetal Exposure During Pregnancy
    End date: 2010-11-01

Flexeril
    Indication: Foetal Exposure During Pregnancy

Multi-Vitamins
    Indication: Foetal Exposure During Pregnancy



Possible Nitrofurantoin side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-13

Patient: male

Reactions: Respiratory Disorder, Glaucoma, Hyperbilirubinaemia, Deafness, Pierre Robin Syndrome, Cleft Palate, Craniosynostosis, Body Dysmorphic Disorder, Developmental Delay

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Multi-Vitamins
    Indication: Foetal Exposure During Pregnancy

Topamax
    Indication: Foetal Exposure During Pregnancy
    End date: 2010-11-01

Flexeril
    Indication: Foetal Exposure During Pregnancy

Nitrofurantoin
    Indication: Foetal Exposure During Pregnancy



Possible Nitrofurantoin side effects in male

Reported by a consumer/non-health professional from United States on 2012-01-04

Patient: male

Reactions: Respiratory Disorder, Hyperbilirubinaemia, Glaucoma, Deafness, Pierre Robin Syndrome, Craniosynostosis, Body Dysmorphic Disorder, Cleft Palate, Developmental Delay

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Flexeril
    Indication: Foetal Exposure During Pregnancy

Nitrofurantoin
    Indication: Foetal Exposure During Pregnancy

Topamax
    Indication: Foetal Exposure During Pregnancy
    End date: 2010-11-01

Multi-Vitamins
    Indication: Foetal Exposure During Pregnancy

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017